BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Y, Huang X, Yuan L, Wang S, Zhang Y, Xiong H, Chen R, Ma J, Qi R, Nie M, Xu J, Zhang Z, Chen L, Wei M, Zhou M, Cai M, Shi Y, Zhang L, Yu H, Hong J, Wang Z, Hong Y, Yue M, Li Z, Chen D, Zheng Q, Li S, Chen Y, Cheng T, Zhang J, Zhang T, Zhu H, Zhao Q, Yuan Q, Guan Y, Xia N. A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters. Sci Transl Med 2021;13:eabg1143. [PMID: 34285130 DOI: 10.1126/scitranslmed.abg1143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, Wu X, Liu J, Zhao D, Li Y. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther 2022;7:94. [PMID: 35322018 DOI: 10.1038/s41392-022-00950-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Cui D, Tang Y, Jiang Q, Jiang D, Zhang Y, Lv Y, Xu D, Wu J, Xie J, Wen C, Lu L. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection. Front Immunol 2021;12:731100. [PMID: 34603308 DOI: 10.3389/fimmu.2021.731100] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Soegiarto G, Fajar J, Wulandari L, Anshory M, Ilmawan M, Asmiragani A, Illiyana H, Adam A, Lamadi S, Sa'adah U, Yuantoko T, Nanda E, Rachmawati F, Rahmadani N, Talilah R, Katipana M, Susanto S, Hindom M, Anjasari U, Hidayah N, Fadilla N, Lekatompessy V, Phoenna U, Tamara F, Kartini D, Mahendra A, Permana A, Pasaribu E, Dhama K, Harapan H. Seroconversion rates among different designs of COVID-19 vaccines: a network meta-analysis of randomized controlled trials. F1000Res 2022;11:299. [DOI: 10.12688/f1000research.110281.1] [Reference Citation Analysis]
4 Tabynov K, Turebekov N, Babayeva M, Fomin G, Yerubayev T, Yespolov T, Li L, Renukaradhya GJ, Petrovsky N, Tabynov K. An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission. NPJ Vaccines 2022;7:24. [PMID: 35197485 DOI: 10.1038/s41541-022-00450-8] [Reference Citation Analysis]
5 Chen X, Shi T, Yang C, Chen F, He X, Zhang K, Hu H, Cai L, Leong KW, Shao D. Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses. Signal Transduct Target Ther 2022;7:96. [PMID: 35338114 DOI: 10.1038/s41392-022-00942-y] [Reference Citation Analysis]
6 da Silva Torres MK, Bichara CDA, de Almeida MDNDS, Vallinoto MC, Queiroz MAF, Vallinoto IMVC, dos Santos EJM, de Carvalho CAM, Vallinoto ACR. The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic. Front Microbiol 2022;13:789882. [DOI: 10.3389/fmicb.2022.789882] [Reference Citation Analysis]
7 van Oosten L, Altenburg JJ, Fougeroux C, Geertsema C, van den End F, Evers WAC, Westphal AH, Lindhoud S, van den Berg W, Swarts DC, Deurhof L, Suhrbier A, Le TT, Torres Morales S, Myeni SK, Kikkert M, Sander AF, de Jongh WA, Dagil R, Nielsen MA, Salanti A, Søgaard M, Keijzer TMP, Weijers D, Eppink MHM, Wijffels RH, van Oers MM, Martens DE, Pijlman GP. Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants. mBio 2021;12:e0181321. [PMID: 34634927 DOI: 10.1128/mBio.01813-21] [Reference Citation Analysis]